In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1‐Ethyl‐1 H ‐Pyrazolo[3,4‐ b ]Pyridine‐Based BRD9 Binders
ChemPlusChem · 2024
DOI: 10.1002/cplu.202400339 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemPlusChem, 2024. Verfasst von Ester Colarusso und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, Fisciano, 84084, Italy. Hauptthemen laut MEDLINE: Transcription Factors, Cell Proliferation, Pyridines, Drug Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC MFAG 2017.
Abstract (Originalsprache)
In this work, we report the identification of novel bromodomain‐containing protein 9 (BRD9) binders through a virtual screening based on our developed 3D structure‐based pharmacophore model. The in silico workflow here described led to the identification of a promising initial hit ( 1 ) featuring the 1‐ethyl‐1 H ‐pyrazolo[3,4‐ b ]pyridine motif which represented an unexplored chemotype for the development of a new class of BRD9 ligands. The encouraging biophysical results achieved for compound 1 prompted us to explore further tailored structural modification around the C‐4 and C‐6 positions of the central core. Hence, the design and synthesis of a set of 19 derivatives ( 2 – 20 ) were performed to extensively investigate the chemical space of BRD9 binding site. Among them, four compounds ( 5 , 11 , 12 , and 19 ) stood out in biophysical assays as new valuable BRD9 ligands featuring IC 50 values in the low‐micromolar range. Noteworthy, a promising antiproliferative activity was detected in vitro for compound 5 on HeLa and A375 cancer cell line. The successful combination and application of in silico tools, chemical synthesis, and biological assays allowed to identify novel BRD9 binders and to expand the arsenal of promising chemical entities amenable to the recognition of this important epigenetic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, Fisciano, 84084, Italy.
- Department of Biosciences and Territory, University of Molise, C.da Fonte Lappone, Pesche, 86090, Italy.
ORCID-Profile: Gianluigi Lauro
Förderung
- AIRC MFAG 2017
Zitieren
APA
Colarusso, E., Gazzillo, E., Pierri, M., Ruggiero, D., Chini, M. G., Bruno, I., Bifulco, G., Terracciano, S., & Lauro, G. (2024). In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1‐Ethyl‐1 H ‐Pyrazolo[3,4‐ b ]Pyridine‐Based BRD9 Binders. ChemPlusChem. https://doi.org/10.1002/cplu.202400339
Vancouver
Colarusso E, Gazzillo E, Pierri M, Ruggiero D, Chini MG, Bruno I, et al. In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1‐Ethyl‐1 H ‐Pyrazolo[3,4‐ b ]Pyridine‐Based BRD9 Binders. ChemPlusChem. 2024. doi:10.1002/cplu.202400339
BibTeX
@article{Colarusso2024,
author = {Colarusso, Ester and Gazzillo, Erica and Pierri, Martina and Ruggiero, Dafne and Chini, Maria Giovanna and Bruno, Ines and Bifulco, Giuseppe and Terracciano, Stefania and Lauro, Gianluigi},
title = {In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1‐Ethyl‐1 H ‐Pyrazolo[3,4‐ b ]Pyridine‐Based BRD9 Binders},
journal = {ChemPlusChem},
year = {2024},
doi = {10.1002/cplu.202400339}
}
EUVIMED